What U.S. Funding Really Supported In Nepal

The fight over “American-funded jobs for transgender workers in Nepal” is not really about identity-based employment at all; it is a dispute over how the United States has long delivered HIV prevention to high‑risk communities abroad, and how that model looks when reduced to a culture‑war headline.

Key Points

U.S. money in Nepal was routed primarily through multi‑year HIV prevention and care programs for so‑called “key populations,” not as stand‑alone transgender employment schemes.
Those programs produced large volumes of concrete health services — condoms, STI treatment, HIV testing, PrEP referrals, and counseling — and often employed LGBTQ+ and transgender staff to reach marginalized groups.
When President Trump froze and then dismantled USAID, clinics and community centers closed, leaving some former outreach workers, including transgender staff, with so few legal job options that they turned to sex work to survive.
The available evidence documents the public‑health rationale and service outputs clearly, but it does not yet answer detailed questions about cost‑effectiveness, overhead, or the exact share of funding that went to salaries versus direct care.

From “transgender jobs” to HIV infrastructure: what the funding actually did

To understand why American money was paying transgender outreach workers in Nepal, you have to start with how global HIV prevention is structured, not with the headline framing. Since the early 1990s, USAID and implementing organizations such as FHI 360 have treated HIV as a chronic epidemic that requires targeted work with groups at higher risk: sex workers, men who have sex with men, transgender women, people who inject drugs, and migrants. In HIV policy jargon, these are “key populations” — communities whose infection rates and network dynamics make them central to whether an epidemic grows or recedes.

USAID’s Nepal program was built squarely around that concept. FHI 360’s own final report describes the Implementing AIDS Prevention and Care (IMPACT) project as the mission’s “primary mechanism” for HIV prevention, care, and mitigation, providing technical assistance to scale services for those most at risk. Later initiatives and spin‑off projects continued the same logic: community‑based outreach to people at risk, linkages to clinical testing and treatment, and support for government surveillance and policy.

In practice, that meant funding a network of support centers and clinics that offered free condoms and lubricants, sexually transmitted infection (STI) diagnosis and treatment, HIV testing and counseling, antiretroviral therapy (ART), pre‑exposure prophylaxis (PrEP), and follow‑up care. Staff were not generic office workers. They were counselors, peer educators, health assistants, and outreach workers, often drawn from the very communities they were trying to reach — including transgender people and other gender and sexual minorities. In conservative settings where openly transgender people have few legal job options, those jobs were both income and a public‑health function.

Scale and outputs: what taxpayers were buying

Critics of foreign aid usually ask two questions: how much did we spend, and what did we get for it? On Nepal, the record answers the second far more clearly than the first. MyRepublica reported that USAID had completed seven HIV/AIDS projects in Nepal since 1993, investing more than US$80 million in the sector over that period. That is not trivial, but it is spread across decades of programming and multiple partners.

What did those dollars purchase? FHI 360’s program materials show extensive service delivery. One USAID‑linked effort reported reaching 1.18 million people with HIV prevention services, diagnosing and treating nearly 92,000 STI cases, providing counseling and testing to almost 135,000 people, and training more than 80,000 individuals in stigma reduction. A later Saath‑Saath newsletter cites more than 1.5 million “key‑population contacts,” nearly 200,000 HIV tests, more than 220,000 instances of STI management, and close to 100 million condoms distributed over two decades.

These figures are self‑reported and not independent audits, but they are internally consistent with the program design and with outside descriptions of the service mix. Put differently: the picture that emerges is not of idle payrolls for symbolic positions; it is of highly routinized outreach and clinic work whose outputs align with standard HIV prevention packages used worldwide.

Why transgender staff were central to the model

The jobs that have become the focus of controversy existed because reaching stigmatized populations through conventional health systems rarely works. People engaged in sex work or living openly as transgender in a conservative society often face harassment, discrimination, or outright violence when they attempt to use mainstream facilities. They may avoid clinics altogether or conceal behaviors that are epidemiologically relevant. Public‑health practitioners have responded by creating “peer‑led” models in which members of key populations are trained and employed to do outreach, counseling, and linkage to services.

In Nepal, that meant that many staff at USAID‑supported centers were themselves transgender or otherwise part of the LGBTQ+ community. AP reporting describes how these workers operated support centers and mobile outreach, providing safe‑sex education, distributing condoms and lubricants, escorting clients to testing sites, and helping maintain adherence to ART or PrEP. The rationale is straightforward: a transgender outreach worker is more likely to be trusted by transgender sex workers than a stranger from outside the community, particularly when stigma and police scrutiny are ever‑present.

Nothing in the publicly available documents suggests that “creating jobs for transgender people” was a separate policy objective detached from HIV outcomes. The programs were structured around disease control; identity‑concordant staffing was a method, not a mission in itself. Nonetheless, because salaries are part of any service program, taxpayers were indeed funding jobs — often for transgender workers — as one component of a larger health infrastructure.

What changed when USAID was dismantled

The controversy over why Americans were funding these jobs flared only after they disappeared. In January 2025, President Trump issued an executive order pausing most foreign aid, followed by a broader dismantling of USAID; by July 1, 2025, the agency had been officially shut down. Contracts and cooperative agreements across developing countries were frozen or terminated, including those underpinning Nepal’s HIV response.

The consequences in Nepal were immediate. The Kathmandu Post reported that HIV prevention efforts “ground to a halt” as outreach programs closed, condom distribution dwindled, and key‑population services were disrupted. AP’s field reporting, echoed by other outlets, documented clinics shuttered, PrEP supply interruptions, and support centers that once offered free condoms, screenings, and follow‑up care closing their doors.

For staff, especially transgender workers already facing limited prospects in a conservative labor market, the loss of those jobs was catastrophic. AP estimated that around 100 LGBTQ+ aid workers in Nepal turned to sex work to survive, walking the same dark highways where they had previously done outreach with free condoms and HIV‑prevention messaging. A widely shared video profile of Rubi Lama, a transgender former outreach worker, captures the pivot starkly: when USAID funding was present, condoms and lubricants were freely available; after the cuts, Lama and others found themselves selling sex in the places they used to serve.

It is that human‑interest narrative — aid workers forced into prostitution — that some commentators in the United States seized upon, asking why American taxpayers were ever paying “transgender sex workers” in Nepal in the first place. The framing collapses the distinction between employing transgender people as health outreach staff and subsidizing sex work itself, even though the jobs existed to reduce HIV risk among sex workers, not to expand the trade.

Evidence for waste versus evidence for health impact

Does the record show that these programs were wasteful or misdesigned? On that question, the available evidence is thinner than either side’s rhetoric. Critics highlight the large numbers — millions of dollars over decades, millions of condoms, hundreds of thousands of tests — as signs of potentially bloated programming. They argue that the mere existence of substantial outputs does not prove value; programs can be expensive, duplicative, or poorly targeted and still report lots of activity.

The documents we have, however, do not include audited cost‑benefit analyses, detailed overhead breakdowns, or alternative scenario modeling. There are no USAID award files in this set showing what proportion of budgets went to salaries, vehicles, clinical supplies, training, or administration; nor do we see Office of Inspector General audits that would quantify inefficiencies. As a result, strong claims either way — “gold‑standard public‑health success” or “boondoggle for NGOs and activists” — outrun what the evidence can currently support.

On the impact side, we can say that the interventions were consistent with global best practice. UNAIDS, UNDP, and HIV.gov all describe community‑led key‑population programs and large‑scale condom distribution, testing, and linkage to care as core to reducing HIV incidence. Columbia University has flagged Nepal’s HIV response as at risk following aid cuts, in the context of a region that saw steep drops in new infections when such programs were fully funded. Yet we still lack a rigorous, Nepal‑specific evaluation that isolates USAID’s contribution and correlates the presence or absence of these particular programs with changes in HIV incidence over time.

Put simply: the programs look like standard, sensible HIV infrastructure, and their sudden removal is widely feared to increase risk. But the fine‑grained efficiency and counterfactual impact questions remain open until more granular data — award ledgers, surveillance trends by district, and independent evaluations — are released.

Why this turned into a culture‑war flashpoint

Foreign aid aimed at stigmatized groups has long been politically vulnerable in donor countries. When a program serves people who are simultaneously poor, foreign, and socially marginalized at home — sex workers, transgender people, drug users — it is easy for commentators to reframe health spending as “identity politics abroad.” That dynamic is visible in the Nepal case. AP, UNAIDS, and FHI 360 describe a public‑health system focused on HIV risk reduction, PrEP access, and stigma reduction, staffed by members of key populations in line with best practice. Critical outlets instead highlight “transgender aid workers” and ask why Americans were paying them, treating identity as the story rather than risk profile and service design.

This reframing matters because it obscures the underlying question citizens actually need answered: not “why help transgender people,” but “how effectively did these programs reduce HIV transmission per dollar spent, and were they the right priority in the portfolio of foreign aid?” Those are empirical questions. They require budgetary transparency, epidemiological data, and rigorous evaluation — all of which are largely absent from the public debate so far.

The institutional silence from USAID’s remnants and implementing NGOs on micro‑level spending and outcomes compounds the problem. In the absence of detailed grant documentation, skeptical audiences can fill the void with speculation, while advocates rely on narrative and self‑reported outputs to defend programs. Neither is a substitute for line‑item budgets and independent audits, which would allow taxpayers to see exactly how much they spent on salaries for transgender outreach workers, how those workers contributed to measurable health gains, and what would likely happen in their absence.

The AP’s Kristen Gelineau, who has been covering the impact of US foreign aid cuts, is reporting on how the cuts have prompted scores of unemployed aid workers in Nepal to turn to sex work to survive. https://t.co/wK5fqbppwO
https://t.co/zPzScqb4Bj

— Steve Herman (@newsguyusa) July 23, 2026

What a serious accountability debate would look like

If the goal is responsible stewardship of taxpayer money rather than symbolic skirmishing, the path forward is straightforward. First, USAID award documents, scopes of work, and quarterly expenditure reports for Nepal’s HIV and LGBTQ+ programs should be released or obtained through oversight mechanisms. Those records would clarify how funds were divided among direct clinical services, outreach and counseling, training, management, and evaluation.

Second, the Nepal Ministry of Health and Population and the National Centre for AIDS and STD Control should provide district‑level surveillance data on HIV incidence and service utilization before, during, and after USAID‑supported interventions. Combined with information on where programs operated, that would allow independent analysts to estimate the causal effect of key‑population programming on the epidemic.

Third, implementer audits and payroll records could separate the cost of employing transgender and other LGBTQ+ staff as outreach workers from broader administrative overhead. That would put hard numbers to the emotionally charged question of “funding jobs for transgender workers” and tie it directly to health results rather than identity debates.

Until that level of transparency exists, the fairest reading of the evidence is this: Americans were funding HIV prevention and care in Nepal through programs that deliberately hired transgender and LGBTQ+ workers as peer educators and counselors. Those jobs disappeared when USAID was dismantled, with grim consequences for the workers and likely for HIV risk in the communities they once served. Whether the spending was optimally designed or efficient is an open empirical question; what it was not, based on the record we have, is a simple identity‑based employment subsidy divorced from public‑health purpose.